Skip to content

LC Bead LUMI

by Biocompatibles UK Limited

510(k) K162373

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK162373 Date16 Dec 2016ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KRD
Device Class
Class II
Regulation
21 CFR Part 870.3300
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The LC Bead LUMI is a vascular embolization device designed to promote occlusion within blood vessels. Classified as a Device for Promoting Embolization, it is intended for use in interventional radiology and cardiovascular procedures to block abnormal blood flow, such as in arteriovenous malformations or hypervascular tumors.

Supplied as a single-use device, the LC Bead LUMI is intended for sterile use in controlled clinical settings. It is categorized under FDA regulation 870.3300 and has received a Traditional 510(k) clearance through the Cardiovascular Advisory Committee. The device is available in various sizes and configurations, as referenced by its associated FEI numbers, and is intended for use in procedures requiring precise vascular occlusion.

Other devices from Biocompatibles UK Ltd

See all devices from Biocompatibles UK Ltd →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of medical procedures is the LC Bead LUMI designed to assist with, and why is it specifically useful in those settings?

    The LC Bead LUMI is designed for interventional radiology and cardiovascular procedures to block abnormal blood flow, such as in arteriovenous malformations (AVMs) or hypervascular tumors. Its purpose is to promote occlusion within blood vessels, making it particularly useful in cases where precise vascular control is required to stop unwanted blood supply to abnormal growths or abnormal connections between arteries and veins.

  • Is the LC Bead LUMI intended for single-use or repeated use, and why does this matter in clinical settings?

    The LC Bead LUMI is supplied as a single-use device, intended for sterile use in controlled clinical settings. This design ensures patient safety by preventing cross-contamination between procedures, reducing the risk of infection, and maintaining consistent performance for each individual case.

  • How do I determine the correct size or configuration of LC Bead LUMI for a specific patient case?

    The LC Bead LUMI comes in multiple sizes and configurations, each referenced by its FEI numbers (e.g., 2245304, 3002808761, etc.). These variations allow clinicians to select the appropriate bead size based on the vessel diameter and occlusion requirements of the procedure. Consulting the manufacturer’s technical documentation or a product catalog will help match the correct FEI number to the clinical scenario.

  • What regulatory pathway was followed for the LC Bead LUMI, and what does this mean for its use in clinical practice?

    The LC Bead LUMI received a Traditional 510(k) clearance through the FDA’s Cardiovascular Advisory Committee, under regulation number 870.3300. This means it was deemed *substantially equivalent* to a legally marketed predicate device, confirming its safety and effectiveness for its intended use in promoting vascular embolization. Clinicians can rely on this clearance as evidence of regulatory review before use.